Clinical Trial Update: Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110 [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety and pharmacokinetic data from a Phase 1/2 study of BSYX-A110 in very low birth weight neonates with neonatal sepsis, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• BSYX-A110

Snippet

Sponsor: Biosynexus Incorporated | Conditions: Neonatal Staphylococcal Sepsis | Phase 1, Phase 2 | Status: COMPLETED